LY4152199, a First-in-Class BAFF-RxCD3 Bispecific Antibody for the Treatment of B Cell Malignancies

被引：0

作者：

Yang, Wei ^{[1
]}

Burns, Colleen ^{[1
]}

Lindquist, Kevin ^{[2
]}

Dobkin, Julie ^{[1
]}

Shin, Hee Rae ^{[1
]}

Nguyen, Cindy ^{[1
]}

Huang, Xiaodong ^{[1
]}

Helms, Whitney ^{[3
]}

Arce, Nicholas ^{[2
]}

Mak, Yvonne ^{[2
]}

Au, Audrey ^{[1
]}

Abouzeid, Abraham ^{[4
]}

Witek, Marta ^{[4
]}

Leow, Ching Ching ^{[1
]}

Gong, Xueqian ^{[4
]}

Srinivasan, Mohan

Park, Joshua I. ^{[2
]}

Driscoll, Kyla ^{[1
]}

Hass, Andrew ^{[4
]}

Holmgaard, Rikke ^{[1
]}

Duramad, Omar ^{[2
]}

Bedard, Kristin ^{[2
]}

机构：

[1] LoxoLilly, New York, NY USA

[2] LoxoLilly, South San Francisco, CA USA

[3] LoxoLilly, Silver Spring, MD USA

[4] Eli Lilly & Co, Indianapolis, IN USA

来源：

BLOOD | 2024年 / 144卷

关键词：

D O I：

10.1182/blood-2024-200316

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2785 / 2786

页数：2

共 50 条

[21] Characterization of anti-CD79b/CD3 bispecific antibody, a potential therapy for B cell malignancies
Wang, Jie
Li, Chen
He, Kaijie
Kuang, Zhihui
Lu, Jia
Yao, Ying
He, Fufan
Li, Ninghuan
Li, Li
Fu, Fenggen
Wu, Zhihai
Zhou, Shuaixiang
Kang, Dian
Qiu, Xuan
Wu, Min
Liu, Yang
Cao, Xiaochao
Xu, Mengqiu
Chen, Bingliang
Wu, Weiwei
Guo, Feng
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (02) : 493 - 507
[22] Characterization of anti-CD79b/CD3 bispecific antibody, a potential therapy for B cell malignancies
Jie Wang
Chen Li
Kaijie He
Zhihui Kuang
Jia Lu
Ying Yao
Fufan He
Ninghuan Li
Li Li
Fenggen Fu
Zhihai Wu
Shuaixiang Zhou
Dian Kang
Xuan Qiu
Min Wu
Yang Liu
Xiaochao Cao
Mengqiu Xu
Bingliang Chen
Weiwei Wu
Feng Guo
Cancer Immunology, Immunotherapy, 2023, 72 : 493 - 507
[23] Preclinical Evaluation of ISB 1442, a First-in-Class CD38 and CD47 Bispecific Antibody Innate Cell Modulator for the Treatment of AML and T-ALL
Stefano, Sammicheli
Grandclement, Camille
Labanca, Valentina
De Angelis, Stefania
Estoppey, Carole
Chimen, Myriam
Pouleau, Blandine
Suere, Perrine
Nallet, Emilie
Srivastava, Ankita
Feldman, Eric J.
Proscurshim, Igor
Konto, Cyril
Zhukovsky, Eugene
Perro, Mario
BLOOD, 2022, 140 : 6237 - 6238
[24] A First-in-Class Bispecific T-Cell Engager for Precursor B-CellAcute Lymphoblastic Leukemia (vol 49, pg 1057, 2015)
Buie, L. W.
Pecoraro, J. J.
Horvat, T. Z.
Daley, R. J.
ANNALS OF PHARMACOTHERAPY, 2016, 50 (01) : 74 - 74
[25] Discovery of JNJ-88549968, a Novel, First-in-Class CALRmutxCD3 T-Cell Redirecting Antibody for the Treatment of Myeloproliferative Neoplasms
Kuchnio, Anna
Samakai, Elsie
Hug, Eva
Balmana, Meritxell
Janssen, Lut
Amorim, Ricardo
Cornelissen, Ivo
Majoros, Andrea
Broux, Michael
Taneja, Isha
Torti, Vince
Agic, Azra
Moritsch, Stefan
Benedetti, Filippo
Rosebrock, Felix
Packman, Kathryn
Arts, Janine
Patel, Sonal
Lomas, Oliver Christopher
Deyoung, M. Phillip
Zagrijtschuk, Oleh
Elsayed, Yusri
Constantinescu, Stefan
Kralovics, Robert
Philippar, Ulrike
BLOOD, 2023, 142
[26] A first-in-class bispecific antibody- drug conjugate (DM002) targeting HER3 and the juxtamembrane domain of MUC1
Zhang, Yifu
Shang, Chenzhang
Wang, Nannan
An, Gao
Zhang, Ellen
Lin, Qingcong
Yang, Yi
CANCER RESEARCH, 2023, 83 (08)
[27] CD20 Tcb (RG6026), a Novel "2:1" T Cell Bispecific Antibody for the Treatment of B Cell Malignancies
Bacac, Marina
Umana, Pablo
Herter, Sylvia
Colombetti, Sara
Sam, Johannes
Le Clech, Marine
Freimoser-Grundschober, Anne
Richard, Marine
Nicolini, Valeria
Gerdes, Christian
Lariviere, Laurent
Neumann, Christiane
Klein, Christian
BLOOD, 2016, 128 (22)
[28] AFM13: a first-in-class tetravalent bispecific anti-CD30/CD16A antibody for NK cell-mediated immunotherapy
Jingjing Wu
Jiaping Fu
Mingzhi Zhang
Delong Liu
Journal of Hematology & Oncology, 8
[29] AFM13: a first-in-class tetravalent bispecific anti-CD30/CD16A antibody for NK cell-mediated immunotherapy
Wu, Jingjing
Fu, Jiaping
Zhang, Mingzhi
Liu, Delong
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2015, 8
[30] Anti-GPC3 TRAB, a first-in-class T cell-redirecting bispecific antibody targeting glypican-3 with potent in vitro and in vivo antitumor efficacy against solid tumors
Kinoshita, Yasuko
Ishiguro, Takahiro
Sano, Yuji
Azuma, Yumiko
Tsunenari, Toshiaki
Ono, Natsuki
Kayukawa, Yoko
Ueda, Otoya
Wada, Naoko A.
Hino, Hiroshi
Jishage, Koichi
Shiraiwa, Hirotake
Kamata-Sakurai, Mika
Nezu, Junichi
Endo, Mika
CANCER RESEARCH, 2016, 76

← 1 2 3 4 5 →